RecruitingNCT00301119

Lung Cancer Biomarkers and Screening

NYU Lung Cancer Biomarker Center

Sponsor

NYU Langone Health

Enrollment

3,606 participants

Start Date

May 1, 2000

Study Type

OBSERVATIONAL

Conditions

Lung Cancer

Summary

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is searching for biological markers in blood and other samples that could serve as early warning signs of lung cancer, potentially allowing it to be caught before symptoms appear. **You may be eligible if...** - You have been diagnosed with lung cancer - You are a current or former smoker who has not been diagnosed with lung cancer (for comparison) - You are willing to provide blood or tissue samples **You may NOT be eligible if...** - You have had a previous cancer other than lung cancer (in some cases) - You are unable to provide informed consent - You are not able to attend the required study visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.